证券代码：600666 证券简称：奥瑞德 公告编号：临 2025-046 奥瑞德光电股份有限公司 关于召开2025年第二次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 2025年第二次临时股东会 召开的日期时间：2025 年 10 月 28 日 14 点 30 分 召开地点：北京市海淀区知春路 68 号领航科技大厦 11 层西侧北京智算力数 股东会召开日期：2025年10月28日 本次股东会采用的网络投票系统：中国证券登记结算有限责任公司股东 会网络投票系统 (二) 股东会召集人：董事会 (三) 投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 字科技有限公司 (一) 股东会类型和届次 (五) 网络投票的系统、起止日期和投票时间。 网络投票系统：中国证券登记结算有限责任公司股东会网络投票系统 网络投票起止时间：自2025 年 10 月 27 日 至2025 年 10 月 28 日 投票时间为：自 2025 ...

Core Viewpoint - The article discusses the rising trend of Real World Assets (RWA) tokenization in the Greater Bay Area, highlighting its potential benefits and challenges for companies seeking to leverage this new financing model [4][5]. Group 1: RWA Tokenization Overview - RWA refers to the tokenization of real-world assets into tradable digital asset certificates using blockchain technology, with over 13 institutions exploring this model in the past two years [4][7]. - Companies are increasingly interested in RWA not just for financing but also for brand exposure and potential stock price enhancement [4][13]. Group 2: Recent Developments and Case Studies - Since 2024, notable companies like Langxin Group and Huaxia Fund have successfully issued RWA projects, with underlying assets including funds, bonds, and real estate [7][8]. - The total market value of global on-chain RWA assets surpassed $25 billion by July 2025, with projections suggesting the market could exceed $10 trillion by 2030 [9]. Group 3: Challenges and Risks - The costs associated with issuing RWA projects in Hong Kong can be high, often exceeding HKD 2.5 million, which may deter some companies from pursuing this route [11][12]. - Not all assets are suitable for RWA; successful tokenization requires stable cash flows, clear legal rights, and verifiable off-chain data [18][19]. Group 4: Regulatory Environment - The regulatory landscape for RWA is still evolving, with a need for clear classification and compliance pathways based on asset characteristics [19][20]. - There are concerns about systemic risks if transparency and custodial measures are not adequately enforced [20][21]. Group 5: Future Prospects - RWA could provide a new avenue for Chinese companies to return to the Hong Kong market, offering a more flexible and faster alternative to traditional secondary listings [24][25]. - The development of RWA is expected to align with economic trends, with potential breakthroughs in cross-border financial products and limited trials for equity assets [25].

Group 1 - Baiyun Airport announces joint investment with China Duty Free Group to establish a duty-free company with a registered capital of 45 million yuan, where China Duty Free Group holds 51% [3] - Dongxing Medical plans to acquire 90% stake in Wuhan Yijiaobao, a high-tech company focused on orthopedic and biomedical materials [4] - Fosun Pharma's subsidiary plans to transfer 100% stake in Shanghai Clone to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [5] Group 2 - Hengxing Technology's subsidiary is awaiting approval for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [6] - New Sai Co. announces resignation of its general manager Chen Jianjiang due to work adjustments [7] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [8] Group 3 - Zhejiang University Network plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [9] - Huazhong Precision terminates the issuance of A-shares to specific targets, affecting a control acquisition [10] - Jiaze New Energy states that its green chemical business is not yet commercially viable, with no significant impact on revenue or profit in the short term [11] Group 4 - Hailan Home plans to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries [12] - Hongfuhang intends to invest up to 1.128 billion yuan in a joint venture to build a photovoltaic energy storage project in Congo [13] - Zhongchuang Zhiling plans to invest 5 billion yuan in a new energy vehicle parts industrial base and R&D center [14] Group 5 - Haitai Development's subsidiary signs a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [15] - Dongjie Intelligent's overseas subsidiary secures a procurement order worth approximately 180 million yuan, representing 22.3% of its audited revenue for 2024 [17] - Zhiguang Electric's subsidiary signs a procurement contract worth 164 million yuan for energy storage systems [18] Group 6 - ST Songfa's subsidiary signs a shipbuilding contract for four VLCCs, with a contract value between 400 million to 600 million USD [19] - Huaguang Huaneng signs a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [20] - Yousheng Co. receives a project notification from a German automaker, with total sales expected to reach approximately 2.3 billion yuan [24] Group 7 - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [25] - Compton plans to reduce holdings of repurchased shares by up to 1% [26] - Aored plans to reduce holdings of repurchased shares by up to 1.29% [27] Group 8 - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a new materials project [34] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [33] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production facility upgrades and working capital [34]

Major Events - Baiyun Airport announced a joint investment with China Duty Free Group to establish a duty-free company at Guangzhou Baiyun Airport with a registered capital of 45 million yuan, where China Duty Free will contribute 22.95 million yuan for a 51% stake [4] - Dongxing Medical plans to acquire 90% of Wuhan Yijiaobao's equity for cash, which is expected to constitute a major asset restructuring [5] - Fosun Pharma's subsidiary is planning to transfer 100% of Shanghai Clon to enhance asset operation efficiency, with a transaction value of up to 1.256 billion yuan [7] - Hengxing Technology's subsidiary is undergoing a review for the extension of mining license for Longtoushan Gold Mine, with exploration activities ongoing [8] - New Sai Co.'s general manager Chen Jianjiang resigned due to work adjustments [9] - Hailiang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange, with details yet to be finalized [10] - Zhejiang University Net announced plans to sell 48.6 million shares of Wanliyang, expecting a transaction amount of 475 million yuan [11] - Huazhong Precision terminated its plan to issue A-shares to specific investors, which also halts the acquisition of control by a third party [12] - Jiazhe New Energy stated that its green chemical business is not yet commercially viable [13] Significant Contracts - Haitai Development's subsidiary signed a property sale contract worth 440 million yuan, expected to increase profits by approximately 62.86 million yuan in 2025 [18] - Dongjie Intelligent's overseas subsidiary received a procurement order worth approximately 180 million yuan, accounting for 22.3% of the company's audited revenue for 2024 [19][20] - Zhiguang Electric's subsidiary signed a procurement contract worth 164 million yuan for energy storage systems [21] - ST Songfa's subsidiary signed contracts for building four oil tankers, with a total value between 400 million to 600 million USD [22] - Huaguang Huaneng signed a sales contract for waste heat boilers worth 160 million yuan for a power plant project in Cambodia [23] - Keda Intelligent plans to issue H-shares and list on the Hong Kong Stock Exchange, with details still under discussion [24] Shareholding Changes - Zai Sheng Technology's controlling shareholder plans to reduce holdings by up to 3% [28] - Compton plans to reduce up to 1% of its repurchased shares [29] - Aorede plans to reduce up to 1.29% of its shares from the repurchased stock [30] - Yidian Tianxia's controlling shareholder plans to reduce up to 3% of its shares [31] - Huace Film's shareholders plan to transfer 3.6% of the company's shares through an inquiry transfer [32] Buybacks and Financing - Qibin Group obtained a special financing support of up to 90 million yuan for share repurchase [33] - CanSino plans to cancel 406,100 repurchased shares and reduce registered capital accordingly [35] Fundraising Initiatives - Xianhe Co. plans to raise up to 3 billion yuan through a private placement for a high-performance paper-based new materials project [36] - Guanshi Technology plans to raise up to 700 million yuan for photomask manufacturing and other projects [37] - Beilu Pharmaceutical plans to raise up to 300 million yuan for production line upgrades and working capital [38]

证券日报网讯9月26日晚间，奥瑞德（600666）发布公告称，公司聘任黄凤英女士为公司总经理。 ...

Core Viewpoint - The company, Aorede (600666.SH), plans to reduce its repurchased shares through centralized bidding, with a maximum of 35,721,000 shares, accounting for 1.29% of its total share capital, during the period from October 31, 2025, to April 30, 2026 [1] Summary by Relevant Sections - **Share Reduction Plan** - The company has approved a plan to reduce its repurchased shares through centralized bidding [1] - The total number of shares to be reduced is up to 35,721,000 [1] - This reduction represents 1.29% of the company's total share capital [1] - **Timeline** - The reduction period is set from October 31, 2025, to April 30, 2026 [1] - **Regulatory Compliance** - The plan is in accordance with the Shanghai Stock Exchange's self-regulatory guidelines regarding share repurchase [1] - It follows the stipulations outlined in the repurchase report disclosed on June 27, 2024 [1]

（记者 曾健辉） 截至发稿，奥瑞德市值为93亿元。 每经头条（nbdtoutiao）——5年增长33倍，这类新险种卖爆了，身边很多人都需要，30多家险企蜂拥而 入⋯⋯ 每经AI快讯，奥瑞德（SH 600666，收盘价：3.36元）9月26日晚间发布公告称，公司第十届第二十五次 董事会会议于2025年9月26日在公司会议室以现场结合通讯方式召开。会议审议了《关于修订、制定、 废止部分治理制度的议案》等文件。 2024年1至12月份，奥瑞德的营业收入构成为：制造业占比62.38%，算力服务占比31.58%，其他业务占 比6.04%。 ...

格隆汇9月26日丨奥瑞德(600666.SH)公布，公司于2025年9月26日召开第十届董事会第二十五次会议， 审议通过了《关于集中竞价减持已回购股份计划的议案》，根据《上海证券交易所上市公司自律监管指 引第7号——回购股份》的规定以及公司于2024年6月27日披露的《关于以集中竞价交易方式回购股份的 回购报告书》的约定用途和要求，公司计划通过集中竞价交易方式减持回购股份合计不超过35,721,000 股（含），不超过公司总股本的1.29%。减持期间为2025年10月31日至2026年4月30日。 ...

证券代码：600666 证券简称：奥瑞德 公告编号：临 2025-044 一、减持主体的基本情况 奥瑞德光电股份有限公司 关于集中竞价减持已回购股份计划的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购股份的基本情况 奥瑞德光电股份有限公司（以下简称"公司"）于 2024 年 6 月 21 日至 2024 年 9 月 20 日期间通过集中竞价交易方式回购公司股份 35,721,000 股（占公司股 份总数的比例为 1.29%），用于维护公司价值及股东权益。以上回购股份将在披 露回购实施结果公告 12 个月后根据相关规则通过集中竞价交易方式出售，并在 披露回购实施结果公告后 36 个月内完成出售。公司如未能在规定期限内完成出 售，未出售的回购股份将全部予以注销。截至本公告披露日，公司尚未减持或转 让前述股份。 减持计划的主要内容 公司于 2025 年 9 月 26 日召开第十届董事会第二十五次会议，审议通过了《关 于集中竞价减持已回购股份计划的议案》，根据《上海证券交易所上市公司自律 监管指引 ...

奥瑞德光电股份有限公司 （2025年9月修订） 第一章 总则 （二）平等性原则。上市公司开展投资者关系管理活动，应当平等对待所有投资者，尤 其为中小投资者参与活动创造机会、提供便利。 （三）主动性原则。上市公司应当主动开展投资者关系管理活动，听取投资者意见建议， 及时回应投资者诉求。 （四）诚实守信原则。上市公司在投资者关系管理活动中应当注重诚信、坚守底线、规 范运作、担当责任，营造健康良好的市场生态。 第一条 为了加强奥瑞德光电股份有限公司（下称"公司"或"本公司"）与投资者和潜在 投资者（以下统称"投资者"）之间的信息沟通，促进投资者对公司的了解和认同，促进二者 间关系的良性发展，提升公司在投资者中的诚信度，实现公司价值和投资者利益的最大化， 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所股票上市规则》 等法律、法规和规范性文件以及《公司章程》，结合本公司实际情况，制定本制度。 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动交流和诉 求处理等工作，加强与投资者之间的沟通，增进投资者对公司的了解和认同，以提升公司治 理水平和企业整体价值，实现尊重投资者、回报投资者、 ...